Quotes for Sensidose Aktiebolag
Right Now
- +/-
- %
- Latest
- High
- Low
- Volume
- Turnover ()
- Time (Latest trade)
Board
CEO
- Jack Spira
Chairperson of the Board
- Kathrine Gamborg Andreassen
Board
- Jostein Davidsen
- Lars Hjarrand
- Tony Brejke
Sensidose Aktiebolag
Sensidose is a pharmaceutical company. The company has developed a system for individualized dosing of tablets, a medical treatment using a dosing device pre-programmed for the patient. The company's product portfolio includes a number of brands and drugs intended for the treatment of, for example, Parkinson's. The main operations are in the Nordic region.
News
- Kommuniké från årsstämma i Sensidose Aktiebolag den 13 juni 2023
- Spotlight: Market Notice 135/23 – Sensidose AB will be delisted after close of market on June 16, 2023
- Sista dag för handel med teckningsoptioner av serie TO 1
- Sensidose Aktiebolags ansökan om avnotering har godkänts
- Spotlight: Market Notice 127/23– Last day of trading in Sensidose AB’s subscription option SENSI TO 1
Largest Owners
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Navamedic ASA | 96,33 | 96,33 | 2023-09-27 |
| Avanza Pension | 0,70 | 0,70 | 2023-09-27 |
| Nevada Konsult AB | 0,32 | 0,32 | 2023-09-27 |
| Ann-Charlotte Parker | 0,22 | 0,22 | 2023-09-27 |
| Viola Vitalis AB | 0,22 | 0,22 | 2023-09-27 |
| Lundbergs Textil AB | 0,16 | 0,16 | 2023-09-27 |
| Harriet Meyerson | 0,14 | 0,14 | 2023-09-27 |
| Johan Sivander | 0,12 | 0,12 | 2023-09-27 |
| Lars Perols | 0,11 | 0,11 | 2023-09-27 |
| Jan Berg | 0,10 | 0,10 | 2023-09-27 |
Insider trading
*Powered by Modular Finance
Key Numbers
*Compiled data from Millistream